Share on

Latin America Antinuclear Antibody Test Market Research Report - Segmented By Disease, Technique, Product, End User & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: March, 2023
ID: 3173
Pages: 145
Formats: report pdf report excel report power bi report ppt

As per the research report, the Latin America Antinuclear Antibody Test Market is valued at USD 141.21 million in 2022 and expected to reach USD 261.31 million by 2027 at a CAGR of 13.10% during the forecast period 2022 to 2027.

The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a person’s autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is often used to diagnose Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis.

Factors such as an increase in the prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, growing economies in this region, and growth in people's awareness of these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. Other factors such as increased healthcare expenditure of people due to growing economies and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as diagnostic errors, product approval, and unavailability of skilled labor are hindering the growth of this market.

The Latin America Antinuclear Antibody Test Market is broadly categorized based on Disease, Technique, Product, and End-Users. Based on Disease, it is further sub-categorized into Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis. Based on Technique, it is segmented into Immunofluorescence, Multiplex, and ELISA. Based on Product, it is divided into Software, Systems, Services, and Reagents & Assay Kits. It is divided into Hospitals and Clinical Labs based on End-Users. As of 2018, Assay Kits & reagents segment accounts for the largest share of the Latin America ANA testing market. It can be because of the growth in several reagent rental agreements. Based on Diseases, Rheumatoid Arthritis is expected to have the largest share in the market until the end of the forecast period due to the increased incidences of rheumatoid arthritis. ELISA is currently leading the market based on the technique used for testing.

Geographically, the Latin American market is segmented into Argentina, Mexico, Brazil, Colombia, and the rest of the countries of South America. Brazil has the most significant market share among all these countries and is also growing at the fastest rate. Mexico comes next to Brazil in terms of growth rate.

Some major companies dominating the market by their products and services include Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample